Ligand Pharmaceuticals Files 8-K on Financials
Ticker: LGNZZ · Form: 8-K · Filed: May 8, 2025 · CIK: 886163
| Field | Detail |
|---|---|
| Company | Ligand Pharmaceuticals Inc (LGNZZ) |
| Form Type | 8-K |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
Related Tickers: LGND
TL;DR
LGND filed an 8-K on May 8th detailing financial results.
AI Summary
Ligand Pharmaceuticals Inc. filed an 8-K on May 8, 2025, reporting on its Results of Operations and Financial Condition. The filing includes financial statements and exhibits, with the company's principal executive offices located in Jupiter, Florida.
Why It Matters
This 8-K filing provides an update on Ligand Pharmaceuticals' financial condition and operational results, which is crucial information for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any significant new risks or negative developments.
Key Players & Entities
- LIGAND PHARMACEUTICALS INC (company) — Registrant
- May 8, 2025 (date) — Date of Report
- Jupiter, Florida (location) — Principal executive offices
- Delaware (location) — State of incorporation
- 770160744 (organization_id) — I.R.S. Employer Identification No.
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Ligand Pharmaceuticals Inc.'s Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.
When was this 8-K report filed?
This 8-K report was filed on May 8, 2025.
Where are Ligand Pharmaceuticals Inc.'s principal executive offices located?
Ligand Pharmaceuticals Inc.'s principal executive offices are located at 555 Heritage Drive, Suite 200, Jupiter, Florida 33458.
What is Ligand Pharmaceuticals Inc.'s state of incorporation?
Ligand Pharmaceuticals Inc. is incorporated in Delaware.
What is the SIC code for Ligand Pharmaceuticals Inc.?
The Standard Industrial Classification (SIC) code for Ligand Pharmaceuticals Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding LIGAND PHARMACEUTICALS INC (LGNZZ).